Medicus Pharma Ltd (MDCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,662 | 9,670 | 3,982 | 4,164 | 5,306 |
| TOTAL | $9,781 | $10,997 | $5,088 | $5,378 | $5,443 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 196 | 938 | 570 | 269 | 278 |
| TOTAL | $196 | $938 | $570 | $269 | $278 |
| Total Assets | $9,978 | $11,935 | $5,658 | $5,647 | $5,721 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,171 | 1,892 | 2,154 | 1,427 | 1,880 |
| Accrued Expenses | 1,560 | 1,828 | 1,062 | 763 | N/A |
| TOTAL | $10,658 | $8,544 | $3,336 | $2,306 | $1,992 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 136 | 142 | 174 | 206 | 237 |
| TOTAL | $125 | $142 | $174 | $206 | $237 |
| Total Liabilities | $10,783 | $8,686 | $3,510 | $2,512 | $2,229 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,029 | 17,816 | 13,495 | N/A | N/A |
| Common Shares | 48,793 | 37,834 | 32,909 | 30,518 | 30,517 |
| Retained earnings | -56,164 | -40,182 | -34,006 | -28,904 | -27,752 |
| Other shareholders' equity | 116 | 0 | 0 | 0 | 0 |
| TOTAL | $-805 | $3,249 | $2,148 | $3,135 | $3,492 |
| Total Liabilities And Equity | $9,978 | $11,935 | $5,658 | $5,647 | $5,721 |